Related Experiment Video
Updated: Apr 12, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and
Paco E Bravo1,2, Abdel Tahari3, Iraklis Pozios4
1Department of Radiology, Johns Hopkins University, Baltimore, MD, USA. pbravo@uw.edu.
Insights
Apparent left ventricular cavity dilatation (LVCD) in hypertrophic cardiomyopathy (HCM) is linked to impaired blood flow and increased heart muscle thickness. These findings suggest both perfusion issues and potential true chamber enlargement contribute to LVCD in HCM patients.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Apparent left ventricular cavity dilatation (LVCD) is observed in hypertrophic cardiomyopathy (HCM) but its underlying mechanisms are not fully understood.
- Investigating the clinical predictors and potential causes of LVCD in HCM is crucial for patient management.
Purpose of the Study:
- To explore the clinical predictors of apparent left ventricular cavity dilatation (LVCD) in patients with hypertrophic cardiomyopathy (HCM).
- To investigate the potential mechanisms contributing to LVCD in HCM, focusing on myocardial perfusion and flow reserve.
Main Methods:
- Sixty-one HCM patients underwent N-13-ammonia PET imaging.
- Evaluated parameters included visual assessment of LVCD, transient ischemic dilatation (TID) index, myocardial blood flow (MBF), coronary flow reserve (CFR), and regional myocardial perfusion (rMP).
- TID index was measured at different time points (2-4 min and 15-20 min).
Main Results:
- Excellent agreement was found between visual LVCD and quantitative TID index.
- LVCD-positive patients exhibited greater left ventricular (LV) thickness but lower stress MBF and CFR compared to LVCD-negative patients.
- Abnormal regional myocardial perfusion (rMP) and a higher TID index at early time points were significantly associated with LVCD.
Conclusions:
- Apparent LVCD in HCM is common and strongly associated with abnormal myocardial perfusion and impaired vasodilator flow reserve.
- The degree of LV hypertrophy plays a role in the development of apparent LVCD.
- Both regional/diffuse subendocardial ischemia and true LV chamber dilatation may contribute to apparent LVCD in HCM.
Background:
Apparent left ventricular cavity dilatation (LVCD) in patients with hypertrophic cardiomyopathy (HCM) is an incompletely understood phenomenon. We aimed at investigating its clinical predictors and potential mechanisms.
Methods:
Sixty one HCM patients underwent N-13-ammonia PET for visual evaluation of LVCD, transient ischemic dilatation (TID) index, myocardial blood flow (MBF), coronary flow reserve (CFR), and regional myocardial perfusion (rMP). TID index was also derived at 2-4 and 15-20 minutes.
Results:
Visual LVCD and quantitative TID (>1.13 abnormal) agreement were excellent (k 0.91; P < .0001). LVCD-positive (n = 32) patients had greater LV thickness (2.26 ± 0.59 vs 1.92 ± 0.41 cm; P = .005), but lower stress MBF (1.66 ± 0.42 vs 2.07 ± 0.46 mL/minute/g; P < .0001), and CFR (1.90 ± 0.46 vs 2.46 ± 0.69; P < .0001) than LVCD-negative (n = 29) patients. Abnormal rMP was present in 31/32 LVCD-positive but only 12/29 (P < .0001) LVCD-negative. TID index was higher at 2-4 (1.30 ± 0.13) than at 15-20 minutes (1.27 ± 0.12; P = .001) in LVCD-positive, whereas it was the same (1.04 ± 0.07 vs 1.04 ± 0.07; P = .9) in LVCD-negative. In multivariate analysis, global peak MBF, abnormal rMP, and LV thickness were the best predictors of LVCD.
Conclusion:
Apparent LVCD is a common finding in HCM, intimately related to abnormal myocardial perfusion, globally impaired vasodilator flow reserve, and degree of hypertrophy. In addition to regional and/or diffuse subendocardial ischemia, some degree of true LV chamber dilatation may also contribute to the occurrence of apparent LVCD in HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology

